Change in AD-like scores after repeated analyses in different laboratories was also higher for CSF p-tau (22%) than for Aβ1-42 (12%) and t-tau (1%) when the same cut-offs were used for each site. The gene discussed is MAPT; the disease is Alzheimer disease.